Gennex Laboratories Ltd specializes in Pharmaceuticals within the Healthcare sector.
Gennex Laboratories Ltd, with Security Code 531739, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
---|---|---|---|---|---|---|---|---|---|
2023-10-01 | 2023-12-31 | 191.44 | 27.65 | 213.97 | 0.16 | -28.18 | 22.54 | -4.54 | 35.15 |
2023-10-01 | 2023-12-31 | 170.78 | 26.38 | 193.21 | 0.15 | -23.75 | 22.43 | -2.02 | 31.58 |
2023-07-01 | 2023-09-30 | 142.45 | 26.59 | 143.03 | 0.15 | -18.75 | 0.59 | -2.03 | 35.46 |
2023-07-01 | 2023-09-30 | 175.79 | 30.66 | 181.77 | 0.17 | -27.97 | 5.98 | -10.35 | 39.52 |
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | 4% |
3 Years: | 4% |
TTM: | 3% |
Compounded Profit Growth | |
---|---|
10 Years: | 50% |
5 Years: | 40% |
3 Years: | 40% |
TTM: | 161% |
Stock Price CAGR | |
---|---|
10 Years: | 28% |
5 Years: | 35% |
3 Years: | 17% |
1 Year: | 127% |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 10% |
3 Years: | 15% |
TTM: | 40% |
Compounded Profit Growth | |
---|---|
10 Years: | 0% |
5 Years: | 43% |
3 Years: | 45% |
TTM: | 170% |
Stock Price CAGR | |
---|---|
10 Years: | 28% |
5 Years: | 35% |
3 Years: | 17% |
1 Year: | 127% |